Randomized, Blinded, Placebo‐ and Positive‐Controlled Crossover Study to Determine the Effect of Deferiprone on the QTc Interval in Healthy Subjects

Publisher： John Wiley & Sons Inc

E-ISSN： 2160-7648|7|1|22-32

ISSN： 2160-763X

Source： Clinical Pharmacology In Drug Development, Vol.7, Iss.1, 2018-01, pp. : 22-32

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Absence of QTc prolongation with betrixaban: a randomized, double-blind, placebo- and positive-controlled thorough ECG study

By Morganroth Joel   Gretler Daniel D   Hollenbach Stanley J   Lambing Joseph L   Sinha Uma  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 1, 2013-01 ,pp. : 5-13

Informa Healthcare

Access to resources Recommend Favorite

Effects of Prulifloxacin on Cardiac Repolarization in Healthy Subjects: A Randomized, Crossover, Double-Blind versus Placebo, Moxifloxacin-Controlled Study

By >   >   Dionisio Paolo  

Clinical Drug Investigation, Vol. 30, Iss. 1, 2010-01 ,pp. : 5-14

Adis International

Access to resources Recommend Favorite

Effects of Bilastine on T-wave Morphology and the QTc Interval: A Randomized, Double-Blind, Placebo-Controlled, Thorough QTc Study

By Graff Claus  

Clinical Drug Investigation, Vol. 32, Iss. 5, 2012-05 ,pp. : 339-351

Adis International

Access to resources Recommend Favorite

Pharmacokinetic-Pharmacodynamic Interaction between Nebicapone, a Novel Catechol-O-Methyltransferase Inhibitor, and Controlled-Release Levodopa/Carbidopa 200 mg/50 mg: Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects

By Vaz-da-Silva Manuel  

Drugs in R&D, Vol. 9, Iss. 6, 2008-01 ,pp. : 435-446

Adis International

Access to resources Recommend Favorite

Safety, Tolerability and Pharmacokinetics of Sugammadex Using Single High Doses (Up to 96 mg/kg) in Healthy Adult Subjects: A Randomized, Double-Blind, Crossover, Placebo-Controlled, Single-Centre Study

By Peeters Pierre A.M.  

Clinical Drug Investigation, Vol. 30, Iss. 12, 2010-12 ,pp. : 867-874

Adis International

Access to resources Recommend Favorite